Literature DB >> 22313910

Bevacizumab (Avastin): An anti-angiogenic drug associated with osteonecrosis of the jaw.

Richard L Wynn1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22313910

Source DB:  PubMed          Journal:  Gen Dent        ISSN: 0363-6771


× No keyword cloud information.
  7 in total

1.  Bevacizumab-associated osteonecrosis of the wrist and knee in three pediatric patients with recurrent CNS tumors.

Authors:  Jason Fangusaro; Sridharan Gururangan; Regina I Jakacki; Sue C Kaste; Stewart Goldman; Ian F Pollack; James M Boyett; Larry E Kun
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

2.  Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).

Authors:  Jason Fangusaro; Sridharan Gururangan; Tina Young Poussaint; Roger E McLendon; Arzu Onar-Thomas; Katherine E Warren; Shengjie Wu; Roger J Packer; Anu Banerjee; Richard J Gilbertson; Regina Jakacki; Amar Gajjar; Stewart Goldman; Ian F Pollack; Henry S Friedman; James M Boyett; Larry E Kun; Maryam Fouladi
Journal:  Cancer       Date:  2013-09-19       Impact factor: 6.860

Review 3.  Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons.

Authors:  Kyoung Min Kim; Yumie Rhee; Yong-Dae Kwon; Tae-Geon Kwon; Jeong Keun Lee; Deog-Yoon Kim
Journal:  J Bone Metab       Date:  2015-11-30

Review 4.  Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature.

Authors:  Kununya Pimolbutr; Stephen Porter; Stefano Fedele
Journal:  Biomed Res Int       Date:  2018-04-23       Impact factor: 3.411

Review 5.  Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology.

Authors:  Antonio Fabrizio Nifosì; Mariateresa Zuccarello; Lorenzo Nifosì; Vanessa Hervas Saus; Gianfilippo Nifosì
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2019-02-26

6.  Pharyngeal spreading of peri-implant infections under antiresorptive/antiangiogenic therapy.

Authors:  Karsten Kern; Fania Lukmann; Karina Obreja; Sara Al-Maawi; Bellinghausen Carla; Shahram Ghanaati; Gernot Rohde; Robert Sader; Frank Schwarz
Journal:  Int J Implant Dent       Date:  2021-06-03

7.  Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons.

Authors:  Jin-Woo Kim; Mi Kyung Kwak; Jeong Joon Han; Sung-Tak Lee; Ha Young Kim; Se Hwa Kim; Junho Jung; Jeong Keun Lee; Young-Kyun Lee; Yong-Dae Kwon; Deog-Yoon Kim
Journal:  J Bone Metab       Date:  2021-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.